Diabetes decisions — 2026

The Board has granted service connection for left and right lower extremity diabetic neuropathy as secondary to the Veteran's service-connected diabetes mellitus, type II.

The Board has restored service connection for diabetes mellitus, type II and its associated lower extremity neuropathies as well as chronic renal disease due to the Veteran's exposure to herbicide agents during his service in Korea.

Entitlement to a rating of 50 percent, but not higher, for chronic headache disorder is granted from April 22, 2023.,Entitlement to a rating of 10 percent, but no higher, for hemorrhoids is granted from April 22, 2024.,Service connection for diabetes mellitus is granted.,Service connection for coronary artery disease, myocardial infarction status post coronary artery bypass graft with stent is granted.,Service connection for an acquired psychiatric disorder (adjustment disorder with mixed anxiety and depressed mood) is granted as secondary to tinnitus.,Service connection for right upper extremity diabetic neuropathy is granted.,Service connection for left upper extremity diabetic neuropathy is granted.

The Board has granted service connection for diabetes, ulcerative colitis, and peripheral neuropathy related to the Veteran's service-connected diabetes. The decision also grants service connection for hypertension as secondary to service-connected diabetes.

The Veteran is granted SMC at the housebound rate effective December 19, 2022. The Board also grants TDIU based on PTSD alone and denies earlier effective dates for DEA benefits and TDIU based on multiple disabilities.

The Board has remanded the claims for service connection for DM, hypertension, hypothyroidism, PN RLE, and PN LLE due to duty to assist errors. Specifically, additional development is needed to verify herbicide agent exposure during service in Korea and a VA opinion is required to address whether these conditions are related to handling barrels of unknown liquid labeled hazardous material.

The Board denied service connection for a right hip disability and type 2 diabetes mellitus, finding that the evidence did not support an in-service disease or injury related to these conditions.,Both the right hip disability and type 2 diabetes mellitus were found to have no onset during service or within one year of separation from service.

The Veteran's claim for service connection for Type II Diabetes Mellitus was granted, with the condition presumed to have had its onset in service.,Service connection was also granted for Diabetic Retinopathy as a complication of the previously established service-connected diabetes.

The Board denied service connection for diabetes mellitus and benign lipomas, finding that the conditions were not related to service or any service-connected disabilities.

The Board has remanded the claims for osteoarthritis, respiratory disorders (asthma and obstructive sleep apnea), eye disorder, and skin disorder due to insufficient opinions regarding their etiology. The claims are being returned to the AOJ for further development.

The Veteran's TDIU claim is granted from September 1, 2008 to May 20, 2015 due to his service-connected disabilities making him unable to secure and maintain substantially gainful employment.

The Board has remanded the case due to the need for additional development, including obtaining an autopsy report and a toxic exposure risk activity memorandum. The cause of death is listed as complications of trauma to the spine with other significant conditions that contributed to death of Parkinson's disease and diabetes mellitus.

The Board denied the Veteran's claim for service connection for diabetes mellitus type II, finding that there was no evidence of in-service onset or relationship to service and rejecting the appellant's assertions regarding exposure to herbicide agents. The Board also found insufficient medical opinion evidence to support a direct service connection.

The Veteran's diabetes is granted as service-connected, and he is awarded a TDIU based solely on his service-connected PTSD prior to August 7, 2020.

The Board has denied the Veteran's claims for service connection for hypertension and diabetes, finding that there is no evidence to support a nexus between these conditions and in-service toxic exposure risk activity.

The Veteran's OSA and DM II are granted as secondary to his service-connected PTSD.

The Veteran's service connection claims for hypertension, diabetes mellitus type 2, and bilateral upper/lower extremity diabetic neuropathies have been granted due to presumed exposure to herbicides during his military service.

The Veteran withdrew their appeal for service connection for diabetes mellitus type II, and the Board has dismissed the case.

The Veteran's limitations in performing activities of daily living are consistent with being unable to sustain himself in the community, warranting Tier 2 benefits under the PCAFC program.